Novel sulfonamides as potential, systemically active antitumor agents.
暂无分享,去创建一个
T. Nagasu | Y. Kotake | J. Niijima | K. Tsukahara | N. Koyanagi | K. Kitoh | K. Yoshimatsu | H. Yoshino | H. Sugumi | M. Asada | Tatsuo Watanabe | N. Ueda | T. Watanabe | N. Ueda | A. Iijima
[1] R. Johnson. Screening methods in antineoplastic drug discovery. , 1990, Journal of the National Cancer Institute.
[2] Grindey Gb. Current status of cancer drug development: failure or limited success? , 1990 .
[3] R. Branda,et al. Immunosuppressive properties of chloroquinoxaline sulfonamide. , 1989, Biochemical pharmacology.
[4] R. Branda,et al. Cellular pharmacology of chloroquinoxaline sulfonamide and a related compound in murine B16 melanoma cells. , 1988, Biochemical pharmacology.
[5] W. V. Ruyle,et al. Synthesis and analgesic-antiinflammatory activity of some 4- and 5-substituted heteroarylsalicylic acids. , 1978, Journal of medicinal chemistry.
[6] V. J. Lotti,et al. Synthesis and analgesic activity of 1,3-dihydro-3-(substituted phenyl)imidazo[4,5-b]pyridin-2-ones and 3-(substituted phenyl)-1,2,3-triazolo[4,5-b]pyridines. , 1978, Journal of medicinal chemistry.
[7] T. Maren,et al. Relatons between structure and biological activity of sulfonamides. , 1976, Annual review of pharmacology and toxicology.
[8] T. A. Connors,et al. The selective concentration of sulphadiazine and related compounds in malignant tissue. , 1973, European journal of cancer.